Philip W. Brickner, MD; Ramon A. Torres, MD; Mark Barnes, JD; Robert G. Newman, MD; Don C. Des Jarlais, PhD; Dennis P. Whalen; David E. Rogers, MD
Brickner PW, Torres RA, Barnes M, Newman RG, Des Jarlais DC, Whalen DP, et al. Recommendations for Control and Prevention of Human Immunodeficiency Virus (HIV) Infection in Intravenous Drug Users. Ann Intern Med. 1989;110:833-837. doi: 10.7326/0003-4819-110-10-833
Download citation file:
Published: Ann Intern Med. 1989;110(10):833-837.
Considerable evidence indicates that intravenous drug users are emerging as the group at greatest risk for both acquiring and spreading human immunodeficiency virus (HIV) infection. Thus, all possible methods to control the spread of HIV infection in intravenous drug users should be explored. Key recommendations are that HIV antibody testing of intravenous drug users should be voluntary, because mandatory testing is counterproductive; free distribution of needles and syringes to intravenous drug users should occur only in carefully controlled circumstances to determine its effectiveness in decreasing infection rates; and drug-free and methadone maintenance treatment programs should be available on demand to all intravenous drug users as a means of reducing the spread of HIV infection. At present, the primary strategy for prevention must be education resulting in behavioral change. Education is currently the only definitive means for controlling the spread of HIV infection among intravenous drug users, their sex contacts, and to fetuses.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, HIV.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only